Dr. Jamal Lewis’s lab is trying to repurpose a fungus to shuttle pharmaceuticals to the central nervous system and treat ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Title: Randomized, Double-Blind Study of BNC210, a Negative Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor, in Posttraumatic Stress Disorder (PTSD): The Attune Trial Presenter: Murray ...

Intra-Cellular submitted its application to the FDA for Caplyta’s approval in major depressive disorder, potentially opening ...

Induced pluripotent stem cell (iPSC)-derived oligodendrocytes represent a viable means of studying oligodendrocyte ...

ATH434 is a Disease Modifying Drug Candidate Targeting Alpha-Synuclein and Iron in Parkinsonian Disorders –– Topline Data Expected in Early ...

Viatris announces its new ARV production facility in Isando, Johannesburg, marking a significant milestone in the fight ...

A health expert has claimed one food is the best thing you can eat for gut health as it's easy to digest and can help improve ...

ED is a common problem that affects men of all ages. In fact, research published by the National Institutes of Health (NIH) ...

A health expert has shared that while vegetables like spinach and kale can be good for you, some people may find them ...

Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) has submitted a supplemental new drug application (SNDA) to the U.S. Food and ...